CHINA PHARMA HOLDINGS, INC. (CPHI)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Revenue | - | 1,136,287 | 1,100,152 | 924,943 |
| Cost of revenue | - | 1,272,348 | 1,619,801 | 1,940,329 |
| Gross loss | - | -136,061 | -519,649 | -1,015,386 |
| Selling expenses | - | 87,111 | 134,603 | 111,455 |
| Research and development expenses | - | 29,587 | 87,610 | 164,334 |
| Credit gains | - | -1,323 | -1,656 | 8,476 |
| General and administrative expenses | - | 507,182 | 345,051 | 91,870 |
| Total operating expenses | - | 622,557 | 565,608 | 376,135 |
| Loss from operations | - | -758,618 | -1,085,257 | -1,391,521 |
| Interest income | - | 1,074 | - | - |
| Interest expense | - | 28,028 | - | - |
| Net other expense | - | -26,954 | - | - |
| Interest expense, nonoperating | - | - | 34,114 | 48,140 |
| Investment income, interest | - | - | 1,460 | 1,531 |
| Loss before income taxes | -528,367 | -785,572 | -1,117,911 | -1,438,130 |
| Income tax expense | - | - | - | - |
| Net loss | -528,367 | -785,572 | -1,117,911 | -1,438,130 |
| Other comprehensive income (loss) - foreign currency translation adjustment | 20,263 | 7,516 | 137,638 | -45,502 |
| Comprehensive loss | -508,104 | -778,056 | -980,273 | -1,483,632 |
| Loss per share basic (in dollars per share) | -0.16 | -0.24 | -0.06 | -0.09 |
| Loss per share diluted (in dollars per share) | -0.16 | -0.24 | -0.06 | -0.09 |
| Weighted average shares outstanding (in shares) | 3,262,002 | 3,261,911 | 17,306,689 | 16,124,241 |